Skip to main content
SpringerLink
Log in

Motor System II: Basal Ganglia

  • Chapter
  • First Online:
Neuroanatomy for the Neuroscientist

  • 3989 Accesses

Abstract

The term “basal ganglia” originally included the deep telencephalic nuclei: the caudate, putamen, globus pallidus, claustrum, and nucleus accumbens. The globus pallidus and putamen are lens shaped and are called lenticular nuclei. Collectively the putamen and caudate are called the corpus striatum. Additional structures now included within this group are the substantia nigra, the subthalamic nuclei, the ventral tegmental area, and the ventral pallidum. One is very familiar with disease of the basal ganglia due to the widespread presence of Parkinson’s disease with its tremor at rest.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  • Albin D, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989;12:366–75.

    Article  CAS  PubMed  Google Scholar 

  • Cooper IS. Involuntary movement disorders. New York: Hoeber Medical Division; 1969a.

    Google Scholar 

  • Cooper JR, Bloom FE, Roth RH. The biochemical basis of neuropharmacology. New York: Oxford University Press. (see in particular chapter 10: dopamine); 1991. p. 285–337.

    Google Scholar 

  • Denny-Brown D. The basal ganglia and their relation to disorder of movement. London: Oxford University Press; 1962.

    Google Scholar 

  • Galvez-Jimenez N, editor. Movement disorders. Semin Neurol. 2001;21:1–123.

    Google Scholar 

  • Hallett M. Classification and treatment of tremor. JAMA. 1991;266:1115–7.

    Article  CAS  PubMed  Google Scholar 

  • Haymaker W, Mehler WF, Schiller F. Extrapyramidal motor disorders. In: Haymaker W, editor. Bing’s local diagnosis in neurological disease. St Louis: CVMosby; 1969. p. 404–40.

    Google Scholar 

  • Hurtig HI, Stern MB, editors. Movement disorders. Neurol Clin. 2001;19:523–788.

    Google Scholar 

  • Jankovic J, Tolosa E, editors. Parkinson’s disease and movement disorders. Baltimore-Munich: Urban & Schwarzenberg; 1988. 499 pp

    Google Scholar 

  • Lowe J, Lennox G, Leigh PN. Disorders of movement and system degenerations. In: Graham DI, Lantos PL, editors. Greenfield’s neuropathology, vol. 2. London: Arnold; 1997. p. 281–366.

    Google Scholar 

  • Marsden CD, Fahn S, editors. Movement disorders II. London/Boston: Butterworths; 1987. 468 pp

    Google Scholar 

  • Noback CR, Strominger NL, Demarest RJ. Chapter 24: The human nervous system; introduction and review. 4th ed. Philadelphia: Lea & Febiger; 1991. p. 375–95.

    Google Scholar 

  • Oppenheimer DR. Diseases of the basal ganglia, cerebellum and motor neurons. In: Adams JH, Corsellis JAN, Dicker LW, editors. Greenfield’s neuropathology. Edward Arnold: London; 1984. p. 700–47.

    Google Scholar 

  • Quinn N. Fortnightly review: Parkinson’s disease: recognition and differential diagnosis. BMJ. 1995;310:447–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rascol O, Lees AJ, editors. Dyskinesias movement disorders. 1999;14 Suppl 1:1–80.

    Google Scholar 

  • Riley DE, Lang AE. Movement disorders. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. Boston: Butterworth Heinemann II; 2000. p. 1889–930.

    Google Scholar 

Specific References and Citations Parkinson Disease

  • Agid Y, Cervera D, Hirsh E, et al. Biochemistry of Parkinson’s disease 28 years later: a critical review. Mov Disord. 1989;4(S1):126–44.

    Article  Google Scholar 

  • Agid Y, Javoy-Agid F, Ruberg M. Biochemistry of neurotransmitters in Parkinson’s disease. In: Marsden CD, Fahn S, editors. Movement disorders II. London/Boston: Butterworths; 1987. p. 166–230.

    Google Scholar 

  • Albin RI, Young AB, Penney JB, et al. Abnormalities of striatal projection neurons and N-methyl D-aspartate receptors in Presymptomatic Huntington’s disease. N Engl J Med. 1990;322:1293–8.

    Article  CAS  PubMed  Google Scholar 

  • Alexander GE, De Long MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci. 1986;9:375–81.

    Article  Google Scholar 

  • Alyward EH, Codori AM, Rosenblatt A, et al. Rate of caudate atrophy in pre-symptomatic and symptomatic stages of Huntington’s disease. Mov Disord. 2000;15:552–60.

    Article  Google Scholar 

  • Aziz TZ, Peggs D, Sambrook MA, Crossman AR. Lesion of the Subthalamic nucleus for the alleviation of l-methyl-4 phenyl 1,2,3,6, Tetrahydropyridine (MPTP) induced parkinsonism in the primate. Mov Disord. 1991;6:288–92.

    Article  CAS  PubMed  Google Scholar 

  • Ballard PH, Tetrud JW, Langston JW. Permanent human parkinsonism due to l-methyl-4 phenyl, 1,2,3,6, tetra-Hydropyrine (mptp): seven cases. Neurology. 1985;35:949–56.

    Article  CAS  PubMed  Google Scholar 

  • Bandmann O, Sweeney MG, Daniel SE, et al. Multiple system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration. Brain. 1997;49:1598–604.

    CAS  Google Scholar 

  • Berciano J. Olivopontocerebellar atrophy. In: Jankovic J, Tolosa E, editors. Parkinson’s disease and movement disorders. Urban & Schwartzenberg: Baltimore/Munich; 1988. p. 131–51.

    Google Scholar 

  • Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the Subthalamic nucleus. Science. 1990;249:1436–8.

    Article  CAS  PubMed  Google Scholar 

  • Bhatia KP. Familial (idiopathic) paroxysmal dyskinesias: an update. Semin Neurol. 2001;21:69–74.

    Article  CAS  PubMed  Google Scholar 

  • Bhatia KP, Griggs RC, Ptacek LJ. Episodic movement disorders as channelopathies. Mov Disord. 2000;15:429–3.

    Article  CAS  Google Scholar 

  • Brashear A. The botulinum toxins in the treatment of cervical dystonia. Semin Neurol. 2001;21:85–90.

    Article  CAS  PubMed  Google Scholar 

  • Brooks DJ. Detection of preclinical Parkinson's disease with PET. Neurology. 1991;41(Suppl 2):24–7.

    Article  CAS  PubMed  Google Scholar 

  • Cooper IS. Involuntary movement disorders. New York: Paul B Hoeber; 1969b.

    Google Scholar 

  • Cote L, Crutcher MD. The basal ganglia. In: Kandel ER, Schwartz JH, Jessell TM, editors. Principles of neural science. 3rd ed. New York: Elsevier; 1991. p. 647–59.

    Google Scholar 

  • Cotzias GC, Papavasiliou PS, Gellen R. Modification of parkinsonism – chronic treatment with L-Dopa. N Engl J Med. 1969;280:337–45.

    Article  CAS  PubMed  Google Scholar 

  • Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. N Engl J Med. 1967;276:374–9.

    Article  CAS  PubMed  Google Scholar 

  • Crossman AR. A hypothesis on the pathophysiological mechanisms that underlie Levodopa or dopamine agonist induced dyskinesia in Parkinson's disease: Implications for the future strategies in treatment. Mov Disord. 1990;5:100–8.

    Article  CAS  PubMed  Google Scholar 

  • Crossman AR, Mitchell IJ, Sambrook MA, Jackson A. Chorea and myoclonus in the monkey induced by gamma amino butyric acid antagonism in the lentiform complex the site of drug action and a hypothesis for the neural mechanism of chorea. Brain. 1988;121:1–33.

    Google Scholar 

  • Daniel SE, de Bruin VM, Lees AJ. The clinical and pathological spectrum of Steele-Richardson Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain. 1995;118:759–70.

    Article  PubMed  Google Scholar 

  • De Bie RMA, Schuurman PR, de Haan PS, et al. Unilateral pallidotomy in advanced Parkinson’s disease: a retrospective study of 26 patients. Mov Disord. 1999;14:951–7.

    Article  PubMed  Google Scholar 

  • Delwaide PJ, Gance M. Pathophysiology of parkinson’s signs. In: Jankovic J, Tolosa E, editors. Parkinson’s disease and movement disorders. Baltimore/Munich: Urban and Schwarzenberg; 1988. p. 59–73.

    Google Scholar 

  • Deuschl G. Treatment options for tremor. N Engl J Med. 2000;342:505–7.

    Article  CAS  PubMed  Google Scholar 

  • Dunnett SB, Bjorklund A. Prospects for new restorative and neuroprotective treatments in Parkinson’s disease. Nature. 1999;399(6738 Suppl):A32–9.

    Article  CAS  PubMed  Google Scholar 

  • Duvoisin RC. Familial Parkinson’s disease. Neurosci News. 1998;1:43–6.

    Google Scholar 

  • Ebersbach G, Sojer M, Valladeoriopla F, et al. Comparative analysis of gait in Parkinson’s disease cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain. 1999;122:1349–55.

    Article  PubMed  Google Scholar 

  • Eidelberg D, Sortel A, Joachim C, et al. Adult onset Hallervorden-Spatz disease with neurofibrillary pathology a discrete clinical pathological entity. Brain. 1987;110:993–1013.

    Article  PubMed  Google Scholar 

  • Fearnley JM, Lees AJ. Striatonigral degeneration. A clinicopathological study. Brain. 1990;113:1823–4.

    Article  PubMed  Google Scholar 

  • Forno LS, Alford EC. Pathology of Parkinson’s disease. In: Roller WC, editor. Handbook of Parkinson’s disease. Marcel-Dekker: NY; 1987. p. 209–36.

    Google Scholar 

  • Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N Engl J Med. 2001;344:710–9. (see also editorial by Fischbach GD, Mc Khann GM. Cell therapy for Parkinson’s disease. Engl J Med. 2001;344:763–5

    Article  CAS  PubMed  Google Scholar 

  • Furukawa Y, Kish SJ. Dopa responsive dystonia: recent advances and remaining issues to be addressed. Mov Disord. 1999;14:709–15.

    Article  CAS  PubMed  Google Scholar 

  • Gerfan CR, Engbar TM. Molecular neuroanatomic mechanisms of Parkinson’s disease. Neurol Clin. 1992;10:435–49.

    Google Scholar 

  • Gibb WRG. The neuropathology of Parkinsonian disorders. In: Jankovic J, Tolosa E, editors. Parkinson’s disease and movement disorders. Baltimore/Munich: Urban & Schwarzenberg; 1988. p. 205–23.

    Google Scholar 

  • Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain. 1989;112:1171–92.

    Article  PubMed  Google Scholar 

  • Goerdert M, Jakes R, Spillantini MG. Alpha-Synuclein and the Lewy body. Neurosci News. 1998;1:47–51.

    Google Scholar 

  • Goetz CG. Charcot on Parkinson's disease. Mov Disord. 1986;1:27–32.

    Article  CAS  PubMed  Google Scholar 

  • Goldblatt D, Markesbery W, Reeves AG. Recurrent Hemichorea following striatal lesions. Arch Neurol. 1974;31:51–4.

    Article  CAS  PubMed  Google Scholar 

  • Graybiel AM, Ragsdale CW. Histochemically distinct compartments in stratum of human, monkey and cat demonstrated by Acetylthiocholinesterase staining. Proc Natl Acad Sci U S A. 1978;75:5723–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Growdon JH, Hirsh MJ, Wurtman RJ, Wiener W. Oral choline administration to patients with tardive dyskinesia. N Engl J Med. 1977;297:524–7.

    Article  CAS  PubMed  Google Scholar 

  • Guridi J, Obesco JA. The subthalamic nucleus, hemiballismus and Parkinson’s disease: reappraisal of a neurosurgical dogma. Brain. 2001;124:5–19.

    Article  CAS  PubMed  Google Scholar 

  • Gusella JF, Wexler NS, Conneally DM, et al. A polymorphic DNA marker genetically linked to Huntington’s disease. Nature. 1983;306:234–8.

    Article  CAS  PubMed  Google Scholar 

  • Guttman M. Dopamine receptors in Parkinson’s disease. Neurol Clin. 1992;10:377–86.

    CAS  PubMed  Google Scholar 

  • Hallett M, Litvan I, et al. Scientific position paper of the movement disorder society evaluation of surgery for Parkinson’s disease. Mov Disord. 2000;15:436–8.

    Article  CAS  PubMed  Google Scholar 

  • Hornykiewicz OD. Physiological, biochemical and pathological backgrounds of Levao-Dopa and possibilities for the future. Neurology. 1970;20:1. (Part 2), 1–13

    Article  CAS  PubMed  Google Scholar 

  • Hornykiewicz O, Kish S, Beckler LE, et al. Brain neurotransmitters in dystonia musculorum deformans. N Engl J Med. 1986;315:347–531.

    Article  CAS  PubMed  Google Scholar 

  • Huntington G. On chorea. Med Surg Report. 1872;26:317–21.

    Google Scholar 

  • Huw RM, Lees AJ, Wood NW. Neurofibrillary tangles Parkinsonian disorders-tau pathology and Taugenetics. Mov Disord. 1999;14:731–6.

    Article  Google Scholar 

  • Jankovic J. Parkinsonism plus syndromes. Mov Disord. 1989a;4(Suppl l):S95–119.

    Article  PubMed  Google Scholar 

  • Jancovic J. Tourette’s syndrome. N Engl J Med. 2001;345:1184–92.

    Article  Google Scholar 

  • Jankovic J, Fahn S. The phenomenology of tics. Mov Disord. 1986;1:17–26.

    Article  CAS  PubMed  Google Scholar 

  • Jankovic J, Fahn S. Dystonic syndromes. In: Jankovic J, Tolosa E, editors. Parkinson’s disease and movement disorders. Baltimore/Munich: Urban & Schwarzenberg; 1988. p. 283–314.

    Google Scholar 

  • Jarman PR, Davis MB, Hodgson SV, et al. Paroxysmal dystonic choreoathetosis: genetic linkage studies in a British family. Brain. 1997;120:2125–30.

    Article  PubMed  Google Scholar 

  • Jarman PR, Bhatia KP, Davie C, et al. Paroxysmal dystonic choreoathetosis: clinical features and investigation of pathophysiology in a large family. Mov Disord. 2000;15:648–57.

    Article  CAS  PubMed  Google Scholar 

  • Kandel E. Disorders of thought: schizophrenia. In: Kandel ER, Schwartz JH, Jessell TM, editors. Principles of neural science. 3rd ed. New York: Elsevier; 1991. p. 853–68.

    Google Scholar 

  • Keenen RE. The Eaton collaborative study of Levo Dopa therapy in parkinsonism. Neurology. 1970;20(Part 2):46–59.

    Article  Google Scholar 

  • Kertesz A. Corticobasal degeneration. J Neurol Neurosurg Psychiatry. 2000;68:275–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kertesz A, Martinez-Lage P, Davidson W, Munoz DG. The Corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology. 2000;55:1368–75.

    Article  CAS  PubMed  Google Scholar 

  • Klawans HL, Moses H, Nausieda DA, et al. Treatment and prognosis of Hemiballismus. N Engl J Med. 1976;295:1348–50.

    Article  CAS  PubMed  Google Scholar 

  • Klawans HL, Paulson GW, Ringel SP, Barbeau A. Use of L-Dopa in the detection of Presymptomatic Huntington's chorea. N Engl J Med. 1972;286:1332–4.

    Article  PubMed  Google Scholar 

  • Klawans HL. The pathophysiology of drug-induced movement disorders. In: Jankovic J, Tolosa E, editors. Parkinson’s disease and movement disorders. Urban and Schwarzenberg: Baltimore/Munich; 1988. p. 315–26.

    Google Scholar 

  • Koller WC, editor. Role of the controlled release formulation of Carbidopa-Levodopa in the treatment of Parkinson’s disease. Neurology. 1992a;42(Suppl 1):Sl–60.

    Google Scholar 

  • Koller WC. Initiating treatment of Parkinson's disease. Neurology. 1992b;42(Suppl 1):29–32.

    Google Scholar 

  • Kopin IJ. MPTP toxicity: Implications for research in Parkinson’s disease. Ann Rev Neurosci. 1988;11:81–96.

    Article  CAS  PubMed  Google Scholar 

  • Lamousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 1998;339:1105–11.

    Article  Google Scholar 

  • Lang AE, Lozano AM. Medical progress: Parkinson’s disease. N Engl J Med. 1998;339:1044–53. 11301143

    Article  CAS  PubMed  Google Scholar 

  • Lang AE, Lozano AM, Duff ME, et al. Posteroventral medial pallidotomy in advanced Parkinson’s disease. N Engl J Med. 1997;337:1036–42.

    Article  CAS  PubMed  Google Scholar 

  • Langston JW, Ballard P. Parkinsonism induced by 1-methyl, 4-phenyl-1,2,3,6, tetrahydropyridine (MPTP): Implications for treatment and pathogenesis of Parkinson’s disease. Can J Neurol Sci. 1984;11:160–5.

    Article  CAS  PubMed  Google Scholar 

  • Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of Meperidine – analog synthesis. Science. 1983;219:979–80.

    Article  CAS  PubMed  Google Scholar 

  • Langston JW, Widner H, Goetz CG, et al. Case assessment program for intracerebral transplantation (CAPIT). Mov Disord. 1992;7:2–13.

    Article  CAS  PubMed  Google Scholar 

  • Laplane D, Levasseur M, Pillone B, et al. Obsessive compulsive and other behavioral changes with bilateral basal ganglia lesions. Brain. 1989;112:699–725.

    Article  PubMed  Google Scholar 

  • Lees AJ, Tolosa E. Tics. In: Jankovic J, Tolosa E, editors. Parkinson’s disease and movement disorders. Baltimore/Munich: Urban and Schwarzenberg; 1988. p. 275–81.

    Google Scholar 

  • Lees AJ. The Steele-Richardson, Olszewski syndrome (progressive Supranuclear palsy). In: Marsden CD, Fahn S, editors. Movement Disorders II. London/Boston: Butterworths; 1987. p. 272–87.

    Google Scholar 

  • Lewin R. Trail of ironies to Parkinson's disease. Science. 1983;224:1083–5.

    Article  Google Scholar 

  • Lewin R. Brain enzyme is the target of drug toxin. Science. 1984;225:1460–2.

    Article  CAS  PubMed  Google Scholar 

  • Le Witt DA. Clinical studies with and pharmacokinetic considerations of sustained release Levodopa. Neurology. 1992;42(Suppl 1):29–31.

    Google Scholar 

  • Lieberman A. Emerging perspectives in Parkinson’s disease. Neurology. 1992;42(Suppl 4):5–7.

    CAS  PubMed  Google Scholar 

  • Lindvall O. Cerebral implantation in movement disorders: state of the art. Mov Disord. 1999;14:201–5.

    Article  CAS  PubMed  Google Scholar 

  • Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 1990;247:514–77.

    Article  Google Scholar 

  • Litwin I. Diagnosis and management of progressive supranuclear palsy. Semin Neurol. 2001;21:41–8.

    Article  Google Scholar 

  • Litwin I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele- Richardson- Olszewski syndrome) from related disorders? A clinicopathological study. Brain. 1997;120:25–9.

    Google Scholar 

  • Martin JB, Gusella JF. Huntington's disease: pathogenesis and management. N Engl J Med. 1986;315:1267–76.

    Article  CAS  PubMed  Google Scholar 

  • Mathuranath PS, Xuereb JH, Bak T, Hodges JR. Corticobasal degeneration and/or frontal temporal dementia? A report of two overlap cases and review of the literature. J Neurol Neurosurg Psychiatry. 2000;68:304–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology. 1985;35:453–61.

    Article  CAS  PubMed  Google Scholar 

  • Meissen GJ, Myers RH, Mastromauro CA, Koroshetz WJ, Klinger KW, Farrer LA, Watkins PA, Gusella JF, Bird ED, Martin JB. Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med. 1988;318(9):535–42.

    Article  CAS  PubMed  Google Scholar 

  • Mena I, Court J, Fuenzalida S, et al. Chronic Manganeses poisoning: treatment with L-Dopa or 5-OH tryptophan. N Engl J Med. 1970;282:5–10.

    Article  CAS  PubMed  Google Scholar 

  • Martin JR. Hemichorea (hemiballismus) without lesions in the corpus Luysii. Brain. 1951;80:1–10.

    Article  Google Scholar 

  • Meyers R, Sweeney DB, Swidde JT. Hemiballismus: etiology and surgical treatment. J Neurol Neurosurg Psychiatry. 1947;58:672–92.

    Google Scholar 

  • Mitchell IJ, Jackson A, Sambrook MA, Crossman AR. The role of the subthalamic nucleus in experimental chorea evidence from 2-Desoxyglucose metabolic mapping and horse radish peroxidase tracing studies. Brain. 1989;112:1533–48.

    Article  PubMed  Google Scholar 

  • Montastruc JL, Rascol O, Senard JM. Treatment of Parkinson’s disease should begin with a dopamine agonist. Mov Disord. 1999;14:725–30.

    Article  CAS  PubMed  Google Scholar 

  • Myers RH, Sax DS, Koroshetz WJ, et al. Factors associated with slow progression in Huntington's disease. Arch Neurol. 1991;48:800–4.

    Article  CAS  PubMed  Google Scholar 

  • Myers RH, Vonsattel JP, Stevens TJ, et al. Pathologic assessment of severity in Huntington’s disease. Neurology. 1988;38:341–7.

    Article  CAS  PubMed  Google Scholar 

  • Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson’s disease. Annu Rev Neurosci. 1999;22:123–44.

    Article  CAS  PubMed  Google Scholar 

  • Papp MI, Lantos PL. The distribution of oligodendroglia inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain. 1994;117:235–43.

    Article  PubMed  Google Scholar 

  • Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely & Jones; 1817. Reprinted - the classics of neurology neurosurgery library, Birmingham, Gryphen editions, 1986

    Google Scholar 

  • Patten BM. Wilson’s disease. In: Jankovic J, Tolosa E, editors. Parkinson’s disease and movement disorders. Baltimore/Munich: Urban & Schwarzenberg; 1988. p. 179–90.

    Google Scholar 

  • Pauls DL, Leckman JF. The inheritance of Gilles de la Tourette's syndrome and associated behaviors: evidence for autosomal dominant transmission. N EngI J Med. 1986;315:993–7.

    Article  CAS  Google Scholar 

  • Pearce RKB. L- Dopa and dyskinesias in normal monkeys. Mov Disord. 1999;14(Suppl 1):9–12.

    PubMed  Google Scholar 

  • Penney JB, Young AB. Huntington’s disease. In: Jankovic J, Tolosa E, editors. Parkinson’s disease. Baltimore: Urban and Schwarzenberg; 1988. p. 167–78.

    Google Scholar 

  • Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration a clinical study of 36 cases. Brain. 1994;117:1183–96.

    Article  PubMed  Google Scholar 

  • Roberts L. Huntington’s gene: so near and so far. Science. 1990;247:624–17.

    Article  CAS  PubMed  Google Scholar 

  • Sarma K, Waltz JM, Riklan M, Koslow M, Cooper IS. Relief of intention tremor by thalamic surgery. J Neurol Neurosurg Psychiat. 1970;33:7–15.

    Article  Google Scholar 

  • Sax DS, Vonsattel JP. Chorea and progressive dementia in an 88-year-old woman. N Engl J Med. 1992;326:117–24.

    Article  Google Scholar 

  • Schmidt WR, Jarcho LW. Persistent dyskinesias following phenothiazide therapy. Arch Neurol. 1966;14:369–77.

    Article  CAS  PubMed  Google Scholar 

  • Schneider JS, Pope A, Simpson K, et al. Recovery from experimental parkinsonism in primates with GM1 Ganglioside treatment. Science. 1992;256:843–6.

    Article  CAS  PubMed  Google Scholar 

  • Scheinberg IH, Steinlieb I. Wilson’s disease. Philadelphia: W B Saunders; 1984.

    Google Scholar 

  • Schuurman PR, Bosch DA, Bossuyt PMM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med. 2000;342:461–8.

    Article  CAS  PubMed  Google Scholar 

  • Schwarz GA, Barrows LJ. Hemiballism without involvement of Luy’s body. Arch Neurol. 1960;2:420–34.

    Article  CAS  PubMed  Google Scholar 

  • Sethi KP. Movement disorders induced by dopamine blocking agents. Semin Neurol. 2001;21:59–68.

    Article  CAS  PubMed  Google Scholar 

  • Siemers E, Reddy V. Profile of patients enrolled in a new movement disorders clinic. Mov Disord. 1991;6:336–41.

    Article  CAS  PubMed  Google Scholar 

  • Singer HS. Current issues in Tourette’s syndrome. Mov Disord. 2000;15:1051–63.

    Article  CAS  PubMed  Google Scholar 

  • Sladek JR, Redmond BE Jr, Collier TJ, et al. Transplantation advances in Parkinson’s disease. Mov Disord. 1989;4(Suppl 1):S120–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Boston, MA, USA

    Stanley Jacobson

  2. Jamaica Plain, MA, USA

    Elliott M. Marcus

  3. South Abington Twp., PA, USA

    Stanley Pugsley

Authors
  1. Stanley Jacobson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elliott M. Marcus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stanley Pugsley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Jacobson, S., Marcus, E.M., Pugsley, S. (2018). Motor System II: Basal Ganglia. In: Neuroanatomy for the Neuroscientist. Springer, Cham. https://doi.org/10.1007/978-3-319-60187-8_12

Download citation

Publish with us

Policies and ethics

Search

Navigation